GANX – gain therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Gain Therapeutics' (GANX) Preclinical Momentum Drives Its Progress in Parkinson's Drug Development [Yahoo! Finance]
Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025
Gain Therapeutics GAAP EPS of -$0.15 beats by $0.01 [Seeking Alpha]
Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update
Form S-8 Gain Therapeutics, Inc.
Form 8-K Gain Therapeutics, Inc. For: Nov 28
Form 424B5 Gain Therapeutics, Inc.
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
Form 8-K Gain Therapeutics, Inc. For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.